L'ANRS à la 6e Conférence de l'IAS (17-20 juillet 2011, Rome, Italie)
La 6e Conférence de l'IAS (Conference on HIV pathogenesis treatment and prevention) se déroulera à Rome en Italie du 17 au 20 juillet 2011
L'ANRS organise un symposium satellite
Mardi 19 juillet de 18h30 à 20h30 (mini room 2)
HIV-2 infection is less frequent than HIV-1 but affects one to two million people, mostly West African patients. Understanding the virus and host mechanisms of this model of attenuated retroviral infection could lead to identify potential means to control HIV infection. Clinical research endpoints and treatment guidelines defined for HIV-1 do not fit and apply to the characteristics of HIV-2 infection and the gold standard therapy remains to be determined through collaborative studies. The satellite symposium aims to present updated data on virological, immunological, and North-South clinical research on this infection.
> Symposium ANRS "HIV-2: a model of attenuated HIV infection"
L'ANRS co-organise un symposium satellite
avec l'Enterprise, l'AVAC, la Communauté européenne, l'IAVI, la Bill & Melinda Gates Foundation, le NIAID
Dimanche 17 juillet de 14h45 à 16h45 (mini room 2)
A safe and effective HIV Vaccine remains our best chance at ending the epidemic. How close are we to developing an HIV Vaccine? What are the latest developments in basic and clinical science? How are these new discoveries informing vaccine design and testing? What might future clinical trials look like in the midst of other new HIV prevention research results?
L'ANRS soutient des colloques affiliés
Vendredi 15 - samedi 16 juillet
"HIV and health systems: leveraging HIV scale-up to strengthen chronic disease services"
ICAP at Columbia University, in collaboration with the International AIDS Society, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the French National Agency for Research on AIDS and Viral Hepatitis (ANRS), the U.S National Institutes of Health (NIH), the U.S. the President’s Emergency Plan for AIDS Relief (PEPFAR), and the NCD Alliance will convene the third in the series of IAS pre-meetings on HIV and health systems, focusing on HIV and non-communicable diseases (NCDs). The meeting will explore ways in which HIV scale-up may be leveraged to strengthen chronic disease services, informing, enhancing, and energizing the systems required to provide continuity care for the millions in need.
Samedi 16 juillet
"New concepts in HIV immunopathogenesis, treatment and vaccines"
Co-organized by the Anrs and the NIH. The meeting will draw key international opinion leaders who will present their innovative views and stimulate debate to help advance these three critical areas of research in HIV infection. Therapeutic successes thus far have brought the dream of a cure closer to reality but more basic understanding of how to control HIV is required. HIV vaccines continue to remain out of reach and ground-breaking ideas are needed that could also contribute to curing HIV. This platform for discussion between prominent vaccine and treatment specialists as well as basic scientists studying the molecular mechanisms of HIV control and immunopathogenesis will provide a unique opportunity to cross-fertilize these different fields.
→ Les Communiqués de presse de l'ANRS : LA CIRCONCISION MASCULINE EN AFRIQUE DU SUD
CP en Français - Circoncision masculine en Afrique du Sud : l'infection des hommes est très réduite
> CP 20 juillet 2011 - circoncision masculine
PR in english - Male circumcision in a South African township is curbing the spread of HIV infection in men
